Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.44 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1345587 | 1.00 | HPGD (0.50) | HPGDSLC6A3MT-CO2PTGS1PTGS2 | |
| SCHEMBL262458 | 1.00 | HPGD (0.50) | HPGDSLC6A3MT-CO2PTGS1PTGS2 | |
| Hydrochloric Acid SCHEMBL6792900 | 0.98 | HPGD (0.49) | HPGDSLC6A3MT-CO2PTGS1PTGS2 | |
| SCHEMBL11130803 | 0.88 | HPGD (0.53) | HPGDMT-CO2PTGS1PTGS2CXCR1 | |
| SCHEMBL12896284 | 0.88 | HPGD (0.53) | HPGDMT-CO2PTGS1PTGS2CXCR1 | |
| SCHEMBL1000872 | 0.84 | LMNA (0.40) | HPGDSLC6A3PTGS2CXCR1CXCR2 | |
| SCHEMBL22838087 | 0.82 | KMT2A (0.55) | HPGDSLC6A3KMT2ASCN1ASCN2A | |
| SCHEMBL1747458 | 0.82 | ESR1 (0.56) | HPGDMT-CO2PTGS1PTGS2KMT2A | |
| SCHEMBL3526852 | 0.82 | ALDH1A1 (0.56) | SLC6A3KMT2ASCN1ASCN2ASCN3A | |
| SCHEMBL12424105 | 0.82 | HPGD (0.51) | HPGDMT-CO2PTGS1PTGS2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117841495-A | Polypropylene synthetic paper with ultrahigh interlayer binding force and preparation method thereof | 烟台富利新材料科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4743082-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL Business Ltd (GB) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025012634-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | WO | disclosed |
| CN-117841495-A | Polypropylene synthetic paper with ultrahigh interlayer binding force and preparation method thereof | 烟台富利新材料科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-117841495-A | Polypropylene synthetic paper with ultrahigh interlayer binding force and preparation method thereof | 烟台富利新材料科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-114292226-B | Compound with hydroxamic acid structure and preparation method and application thereof | 沈阳药科大学 | 2023-04-18 | — | — | CN | disclosed |
| US-20220324803-A1 | PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF | TEON THERAPEUTICS INC (US) | 2022-10-13 | — | — | US | disclosed |
| EP-4019518-A1 | TYK2 INHIBITORS AND USES THEREOF | Nimbus Lakshmi, Inc. (US) | 2022-06-29 | — | — | EP | disclosed |
| EP-4019518-A1 | TYK2 INHIBITORS AND USES THEREOF | Nimbus Lakshmi, Inc. (US) | 2022-06-29 | — | — | EP | disclosed |
| EP-3983412-A1 | PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF | Teon Therapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| US-4308208-A | α-Methylthio-α-(p-phthalimidophenyl)-propionic acid | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1981-12-29 | — | — | US | disclosed |
| US-4278802-A | METHYLTHIO-/P-/2-THIENYLCARBONYL/PHENYL/PROPIONIC ACID OR ESTER, PHARMACEUTICAL INTERMEDIATES | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1981-07-14 | — | — | US | disclosed |
| US-4256753-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | DAINIPPON PHARMACEUTICAL CO., LTD. (JP) | 1981-03-17 | — | — | US | disclosed |
| US-4242519-A | DRUG INTERMEDIATES | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1980-12-30 | — | — | US | disclosed |
| US-4237298-A | Aromatic acetic acid derivatives having sulfur atom at alpha-position and process for their preparation | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1980-12-02 | — | — | US | disclosed |
| EP-0011854-A1 | 4-(2'-Pyridylamino)-phenylacetic acid derivatives, process for their preparation, pharmaceuticals containing these compounds and their use | Dainippon Pharmaceutical Co., Ltd. (JP) | 1980-06-11 | — | — | EP | disclosed |
| EP-0011854-A1 | 4-(2'-Pyridylamino)-phenylacetic acid derivatives, process for their preparation, pharmaceuticals containing these compounds and their use | Dainippon Pharmaceutical Co., Ltd. (JP) | 1980-06-11 | — | — | EP | disclosed |
| US-4144248-A | Aromatic acetic acid derivatives having sulfur atom at alpha-position and process for their preparation | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1979-03-13 | — | — | US | disclosed |
| US-3973022-A | Quinolineacetic acid compositions | CIBA-GEIGY CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3957850-A | ANALGESICS, ANTIINFLAMMATORY AGENTS | BOUCHARA EMILE | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324803-A1 | PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF | PTGER4, PTGER1, PTGER2 | HPGD 42/4885SLC6A3 4136/4885MT-CO2 2122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.